Kiev. Ukraine. Ukraine Gate – January 27, 2021 \u2013 Health<\/p>\n
A new experimental melanoma vaccine can effectively fight it. Tests have shown that protection lasts for at least 4 years after vaccination.<\/p>\n
<\/p>\n
So scientists from Harvard Medical School and the Broad Institute tested the vaccine on 8 patients with melanoma.<\/p>\n
<\/p>\n
The researchers took samples of melanoma, which were removed from patients during the operation. Based on them, a personalized vaccine was created for each study participant.<\/p>\n
<\/p>\n
By studying the RNA of the cells taken, the researchers<\/a> predicted which unique proteins (neoantigens) could be incorporated into different cancer cells.<\/p>\n <\/p>\n The fact is that neoantigens act on the immune system, quite provocatively. Because the final vaccine contained segments of these neoantigens, the T cells of the patients were able to quickly track down the cancer cells.<\/p>\n <\/p>\n The vaccine protected 6 of the 8 participants.<\/p>\n <\/p>\n So according to the results of the study, we can draw the following conclusions:<\/p>\n <\/p>\n